New Mexico MPJE Practice Exam Prep

The FDA's Abbreviated New Drug Application (ANDA) process allows generic drug manufacturers to:

Skip all clinical testing Demonstrate bioequivalence to a reference listed drug without repeating full clinical trials Market drugs without FDA approval Use any inactive ingredient without restriction

Correct Answer:

Demonstrate bioequivalence to a reference listed drug without repeating full clinical trials

Access more questions from this quiz

Continue to New Mexico MPJE Practice Exam Prep for more practice questions and the full quiz experience.

Access More Questions